Envoy Medical, Inc. (NASDAQ:COCH) Sees Significant Decline in Short Interest

Envoy Medical, Inc. (NASDAQ:COCH) was the recipient of a significant decrease in short interest in the month of November. As of November 30th, there was short interest totalling 287,000 shares, a decrease of 19.2% from the November 15th total of 355,300 shares. Currently, 3.7% of the shares of the company are short sold. Based on an average daily trading volume, of 233,600 shares, the short-interest ratio is presently 1.2 days.

Analyst Ratings Changes

COCH has been the subject of several research reports. Brookline Capital Management began coverage on Envoy Medical in a report on Monday, October 14th. They set a “buy” rating and a $9.00 price target for the company. Ascendiant Capital Markets boosted their price target on Envoy Medical from $8.75 to $9.00 and gave the company a “buy” rating in a research note on Friday, December 6th.

Envoy Medical Stock Down 5.8 %

NASDAQ COCH traded down $0.12 during trading on Friday, hitting $1.96. 55,319 shares of the company’s stock were exchanged, compared to its average volume of 192,927. Envoy Medical has a fifty-two week low of $1.08 and a fifty-two week high of $11.46. The stock’s 50 day moving average price is $2.35 and its two-hundred day moving average price is $2.54.

About Envoy Medical

Envoy Medical, Inc, a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc in September 2023.